Beam Therapeutics Inc (NASDAQ: BEAM) flaunted slowness of -3.21% at $28.0, as the Stock market unbolted on Thursday, before settling in for the price of $28.93 at the close. Taking a more long-term approach, BEAM posted a 52-week range of $13.52-$35.25.
The Healthcare sector firm’s twelve-monthly sales growth has been -20.88% for the last half of the decade. Meanwhile, its Annual Earning per share during the time was -20.88%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 5.54%. This publicly-traded company’s shares outstanding now amounts to $101.36 million, simultaneously with a float of $91.58 million. The organization now has a market capitalization sitting at $2.84 billion. At the time of writing, stock’s 50-day Moving Average stood at $25.27, while the 200-day Moving Average is $21.17.
Beam Therapeutics Inc (BEAM) Ownership Facts and Figures
Sometimes it is also beneficial to study the sentiment of large-scale investors towards the stock of the Beam Therapeutics Inc industry. Beam Therapeutics Inc’s current insider ownership accounts for 9.75%, in contrast to 93.02% institutional ownership. According to the most recent insider trade that took place on Dec 31 ’25, this organization’s Chief Financial Officer sold 6,294 shares at the rate of 27.10, making the entire transaction reach 170,567 in total value, affecting insider ownership by 73,706. Preceding that transaction, on Dec 31 ’25, Company’s Chief Legal Officer sold 1,254 for 27.10, making the whole transaction’s value amount to 33,983. This particular insider is now the holder of 115,667 in total.
Beam Therapeutics Inc (BEAM) Earnings and Revenue Records
Beam Therapeutics Inc’s EPS increase for this current 12-month fiscal period is 5.54% and is forecasted to reach -4.65 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will decrease by -1.05% through the next 5 years, which can be compared against the -20.88% growth it accomplished over the previous five years trading on the market.
Beam Therapeutics Inc (NASDAQ: BEAM) Trading Performance Indicators
Let’s observe the current performance indicators for Beam Therapeutics Inc (BEAM). It’s Quick Ratio in the last reported quarter now stands at 6.02. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 51.01.
In the same vein, BEAM’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.43, a figure that is expected to reach -1.01 in the next quarter, and analysts are predicting that it will be -4.65 at the market close of one year from today.
Technical Analysis of Beam Therapeutics Inc (BEAM)
Now, what If we examine the latest scores posted by [Beam Therapeutics Inc, BEAM]. During the last 5-days, its volume was better the volume of 1.74 million it reported in year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 51.14% While, its Average True Range was 55.53.
Raw Stochastic average of Beam Therapeutics Inc (BEAM) in the period of the previous 100 days is set at 77.79%, which indicates a major rise in contrast to 46.81% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 1.41 that was lower than 1.55 volatility it exhibited in the past 100-days period.
